. Purpose: Erythropoietin is responsible for regulating the growth and development of red blood cells. Reports conflict on whether skeletal muscle is able to produce erythropoietin and release it into circulation and if exercise affects this. We set out to determine how erythropoietin is regulated in skeletal muscle and to determine whether skeletal muscle-derived erythropoietin can stimulate erythropoiesis. Methods: Using an in vitro approach, we exposed proliferating and differentiated skeletal muscle cells to various forms of exercise-induced physiological stimuli and measured erythropoietin gene expression. To understand if skeletal muscle cells were able to stimulate erythropoiesis, independent of other cell types found in skeletal muscle, we used myoblastconditioned media to treat bone marrow and to measure erythropoiesis through flow cytometry. We also measured erythropoietin expression and hypoxia in mice subjected to an exercise protocol designed to induce skeletal muscle oxygen stress. Results: Hypoxia increased erythropoietin expression in C2C12 myoblasts, myotubes, and primary myoblasts in vitro by 50% to 130%. Bone marrow treated with media conditioned with hypoxic myoblasts for 24 h increased the number of Ter-119-positive cells by 32%. An erythropoietin-neutralizing antibody prevented this increase. Compared with unexercised controls, exhaustive exercise increased skeletal muscle HIF1> levels by 50% and HIF2> levels by 20%. Moreover, exercised skeletal muscle erythropoietin expression was 70% higher.
P roduced primarily by the kidney, erythropoietin (EPO) is known for its role in regulating erythropoiesis. EPO production is controlled by HIF1 and HIF2 availability. Under normoxic conditions HIF1> and HIF2> are ubiquitinated and degraded in an oxygen-dependent manner. During periods of hypoxia, interstitial fibroblasts in the kidney sense oxygen deficiency and stabilize these isoforms. They then heterodimerize with HIF1A, translocate to the nucleus, bind the hypoxia responsive element on the EPO promoter, and upregulate expression of EPO (9, 21) . Once produced and released into circulation, EPO interacts with the EPO receptor on immature erythrocyte precursors and promotes their survival and maturation (7) . In a negative feedback loop, this increases red blood cell number, alleviates tissue hypoxia, and increases HIF> degradation, which reduces EPO expression. Through this mechanism, the kidney and the EPO serve as a sensor, maintaining oxygen homeostasis.
Because of the central role played by EPO and erythropoiesis in oxygen absorption, transportation, and utilization, many attempts have been made to determine whether exercise can increase circulating EPO and stimulate erythropoiesis, as exercise is strongly limited by these factors. The majority of studies conclude that, across a variety of types, durations, and intensities of exercise, increases in circulating EPO concentrations are not associated with exercise (4, 12, 13, 19, 24, 25) . However, when exercise is combined with hypoxia, or severe hypoxemia is induced by exercise, circulating concentrations of EPO increase (22, 24) . Very long-term and damaging exercise, capable of inducing hemolysis, has also been shown to increase circulating EPO and erythropoiesis (27) .
Skeletal muscle experiences severe oxygen stress during exercise. The tissue adapts by stabilizing HIF1>, resulting in subsequent increases in oxidative capacity and angiogenesis, in an attempt to restore oxygen balance (17) . As might be expected from this pathway, skeletal muscle has also been shown to express EPO. Not only that, exercise has been shown to increase EPO expression in skeletal muscle. Rundqvist et al. (23) had 10 males perform 65 min of cycle exercise. Although they were not able to demonstrate an increase in EPO expression postexercise, they were able to observe an increase in the arteriovenous difference of circulating EPO. Ameln et al. (2) had males perform 45 min of one-legged knee extension exercise while blood flow to the leg was either restricted or left unrestricted. In both conditions, they were able to observe increased expression of skeletal muscle EPO 360 min postexercise. Finally, previous work from our laboratory demonstrated that in mice, treadmill trained on a regular basis for 2 months, basal skeletal muscle EPO expression was greater than sedentary controls. Perplexingly, EPO expression in the kidneys of treadmill trained mice was decreased when compared with sedentary controls (3) .
Is it possible that skeletal muscle, in conjunction with exercise, is able to express EPO at physiologically relevant levels? While it seems that total serum EPO may not increase as a result of the exercise training, skeletal muscle, in conjunction with the kidney, may still be able to contribute to the EPO pool. Given these previous findings, we set out to understand how exercise and skeletal muscle contribute to the production of EPO, if myoblasts and myotubes themselves express EPO, how the process might be regulated, and whether any of this is able to exert a physiological effect on erythropoiesis.
METHODS

Animals
Adult male C57Bl/6 mice (Jackson Laboratories), age 5 wk, were exercised. No more than 5 mice were housed per cage (27 Â 12 Â 15.5 cm). Animals were provided food and water ad libitum. Mice were maintained on a 12-h light-12-h dark cycle at 22-C T 2-C. Ethics approval was granted by the McMaster University Animal Research Ethics Board and conformed to the guidelines of the Canadian Council on Animal Care.
Animal Exercise
Mice were exercised (n = 8) on an Exer 6 M Treadmill (Columbus Instruments Inc., Columbus, OH). The mice were allowed to acclimatize to the treadmill a week before exercise. The acute exercise protocol used consisted of a 10-min warm-up at 12 mImin j1 followed by a 1-h exercise period at 16 mImin . Mice were encouraged to run using a mild electric shock. Resting control mice (n = 8) were exposed to the treadmill and similar encouragements on the same days as exercised mice but were not exercised.
Animal Sacrifice and Tissue Collection
Resting and exercised mice were killed immediately after their exercise period. Mice that were unable to continue were killed at once. Mice were euthanized via cervical dislocation. Lower-leg muscle groups were isolated and flash frozen in liquid nitrogen. This dissection was completed within 1 to 2 min to account for the short half life of HIF1>/ 2> (8) . An additional group of resting mice (n = 6) were used for the erythropoiesis assay. These mice were euthanized via cervical dislocation, and both femurs and tibiae were excised, dissected of muscle and fat, and flushed with IMDM (Sigma-Aldrich, St. Louis, MO) with 2% fetal bovine serum (FBS) (Life Technologies Inc., Rockville, MD) to collect bone marrow. Mononuclear cells were then isolated with Ficoll-Paque (GE Healthcare Life Sciences, Mississauga, ON, Canada).
Cell Culture
C2C12 myoblasts (cat no. CRL-1772, ATCC) were grown at 37-C in 5% CO 2 in growth media (DMEM supplemented with 10% FBS and 1% penicillin/streptomycin; Life Technologies Inc.). Myoblasts were differentiated by switching to differentiation media (DMEM supplemented with 2% horse serum and 1% penicillin/streptomycin; Life Technologies Inc.) for 5 d. Regular DAPI (Life Technologies) staining was performed to rule out any mycoplasma contamination.
In Vitro Model of Exercise
Proliferating or differentiated C2C12 myoblasts (n = 8) were exposed to various physiological stimuli known to occur during aerobic type exercise. RNA was isolated after exposure to each condition. These stimuli are discussed in the following sections.
Mechanical stretch. Proliferating C2C12 myoblasts or terminally differentiated C2C12 myotubes were cultured on type I collagen-coated flexible-bottom plates (Flexcell International, Hillsborough, NC) in growth media or differentiation media, respectively. Proliferating cells were allowed to adhere for 12 h, whereas myotubes were induced to fuse for 7 d before mechanical stimulation. The stretch protocol, previously tested for this cell line (10) , consisted of cyclic strain at 0.1 Hz (8 s of stretch alternated with 2 s of rest) of a 20% strain for a period of 4 h. Stretch was applied using the FX4000i Tension Plusi (Flexcell International), a vacuum stretch apparatus coupled with computer software. Myoblasts and myotubes cultured in a similar fashion, but not exposed to mechanical stimulation, served as controls.
Hypoxia. Proliferating C2C12 myoblasts or terminally differentiated myotubes were exposed to 1% O 2 and 5% CO 2 for 4 h. This is a common treatment for this cell line, and no death was observed during this treatment (14) . Proliferating C2C12 myoblasts or terminally differentiated myotubes that were cultured as normal served as controls. An enzyme-linked immunosorbent assay (ELISA; cat no. MEP00B, R&D Systems, Minneapolis, MN) was used to analyze EPO concentrations in normoxic and hypoxicconditioned media for both proliferating C2C12 myoblasts and differentiated C2C12 myotubes, as well as uncultured growth and differentiation media.
Decreased pH. Proliferating C2C12 myoblasts or terminally differentiated C2C12 myotubes were exposed to regular growth media or differentiation media, respectively, at a pH of 6.6 for 4 h. This pH was chosen to mimic pH observed in muscle during exercise and recovery (1) . No cell death was observed during this treatment. Regular growth or differentiation media (pH of 7.4) was used as a control.
Increased temperature. Proliferating C2C12 myoblasts or terminally differentiated C2C12 myotubes were exposed to a temperature of 41-C for 2 h. This is a mild, commonly used, heat shock protocol for this cell line, and no cell death was observed during this treatment (15) . Proliferating C2C12 myoblasts or terminally differentiated myotubes exposed grown at regular temperature (37-C) were used as a control.
Erythropoiesis Assay and Flow Cytometry
Proliferating C2C12 myoblasts in growth media were exposed to hypoxia for 4 h, as mentioned previously, and media from those cells were collected and filtered. Media from cells grown in typical conditions served as a control. Bone marrow, collected previously (n = 6), was then treated with either the hypoxic-conditioned or the control media and cultured at 37-C and 5% CO 2 for 24 h or 72 h. Bone marrow cells were treated with or without an EPO-neutralizing antibody, at 0.5 KgImL j1 , and changed every 6 h, for the 24 h experiment (cat no. AF959, R&D Systems). Cells were then collected, washed, and stained as per manufacturer recommendation with TER-119 (cat no. 553672, BD Biosciences), a marker of murine hematopoietic cells in the erythroid lineage (11) . After incubation with the primary antibody, cells were treated with a streptavidin FITC secondary antibody at 1:800 (cat no. SNN1008, Life Technologies), washed, and immediately analyzed by flow cytometry (Cyflow Space, Partec).
Reverse Transcriptase and Quantitative Polymerase Chain Reaction
Total RNA was isolated from exercised and resting gastrocnemius muscle and proliferating and differentiated C2C12 myoblasts using a combination TRIzol (Life Technologies Inc.) and total RNA kit (Omega Bio-Tek) method. RNA was reverse transcribed using a commercially available kit (high-capacity cDNA reverse transcription kit; Life Technologies Inc.) with a Mastercycler epGradient Thermal Cycler (Eppendorf Canada, Mississauga, Ontario). Quantitative reverse transcriptase polymerase chain reaction (RT-PCR) reactions were conducted using a Stratagene Mx3000P real-time PCR System (Agilent Technologies, Santa Clara, CA) or a Mastercycler epRealplex 2S qPCR (Eppendorf Canada) with epMotion 5075 (Eppendorf Canada). All samples were normalized to GAPDH, and fold changes in gene expression were calculated using the $$C t method (16) . Some reports indicate that GAPDH is responsive to hypoxia and thus may not be an appropriate normalizing gene; however, there were no observed differences in GAPDH expression in either skeletal muscle or cell lysate in any experimental condition. Previously published primer sequences were used for EPO (3).
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis and Immunoblotting
Muscle protein (50 Kg per lane), isolated through homogenization of gastrocnemius samples in RIPA buffer (SigmaAldrich), was resolved using common sodium dodecyl sulfate-polyacrylamide gel electrophoresis conditions. Proteins were transferred to a polyvinylidene fluoride membrane (Millipore). HIF1> was probed for with an HIF1> antibody (cat no. NB100-449, Novus Biologicals) at a concentration of 1:250 in 5% milk powder (Sigma-Aldrich). HIF2> was probed for with an HIF2> antibody (cat no. AF2997, R&D Systems) at 2 KgImL j1 in 5% milk powder. In both cases, an actin antibody (cat no. A2066, Sigma-Aldrich) at 1:1000 in 5% milk powder was used as a loading control. An antirabbit horseradish peroxidase antibody (cat no. ab6721, Abcam) at 1:25,000 in 5% milk powder was used as a secondary antibody for HIF1> and actin, whereas an antigoat horseradish peroxidase antibody (cat no. A16142, Life Technologies Inc.) at 1:10,000 in 5% milk powder was used as a secondary antibody for HIF2>. Images were captured and analyzed with a FluorChem SP (ProteinSimple, San Jose, CA).
Proliferating Mouse Primary Myoblast EPO Expression
Five 8-wk-old C57Bl/6 mice (Jackson Laboratories) were euthanized via cervical dislocation. Primary myoblasts were isolated from the lower limb muscle of these mice using collagenase and dispase (20) . Ham_s F10 media (SigmaAldrich) supplemented with 20% FBS, 1% penicillin/ streptomycin, and 2.5 ngImL j1 bFGF (Life Technologies Inc.) was used to culture these cells. Myoblasts were purified to 99% positive using a Beckman Coulter MoFlo XDP with an >7-integrin antibody (cat no. K0046-5, MBL International), as described in more detail elsewhere (5) . When the cells had grown to sufficient number, they were exposed to hypoxia for 4 h, RNA was isolated, and RT and qPCR on EPO was performed (same as previously mentioned). Normoxic primary myoblasts served as controls.
Statistics
Data are expressed as means T SE with P e 0.05 considered significant. Statistical differences between resting and exercised groups were determined using two-tailed t-tests with SigmaPlot 11 (Systat Software
production remained unknown. Moreover, whether skeletal muscle myoblasts and myotubes were responsible for expressing EPO, and not some other cell type within skeletal muscle, was also unclear. To determine how exercise might affect myoblast and myotube EPO expression, we tested these cell types isolated in culture against stimuli known to be associated with exercising muscle. When muscle is activated continuously a decrease in pH, an increase in temperature, exposure to hypoxia, and mechanical stretch all occur. Of the conditions tested, only hypoxia was able to stimulate an increase in EPO expression. In C2C12 myoblasts, exposure to 4 h of hypoxia increased EPO expression by 130% (P G 0.05) (Fig. 1A) . In C2C12 myotubes, exposure to 4 h of hypoxia increased EPO expression by 50% (P G 0.05) (Fig. 1B ). An ELISA was used to confirm the presence of EPO in the hypoxic-conditioned media. Hypoxic-conditioned growth and differentiation media contained 36.3 T 12.1 pgImL j1 and 39.7 T 9.5 pgImL j1 of EPO, respectively, while normoxic and control uncultured growth and differentiation media contained no detectable EPO (P G 0.05). No other stimuli were able to alter EPO expression in a significant manner.
EPO expression in proliferating primary myoblasts. C2C12 myoblasts are a transformed cell line, and some believe that they have gained multiple features generally not associated with skeletal muscle. To verify the physiological relevance of the C2C12 findings and to ensure that EPO expression was not such a feature, EPO expression was measured in proliferating primary myoblasts exposed to hypoxia. Proliferating primary myoblasts subjected to 4 h of hypoxia demonstrated a 128% T 6.6% increase in EPO expression, when compared with normoxic proliferating primary myoblast controls (P G 0.05).
Exercise stabilizes HIF> isoforms and increases EPO expression in skeletal muscle. Given that skeletal muscle myoblasts and myotubes were able to express EPO directly, and did so in response to hypoxia, we set out to determine the mechanism by which this might occur. EPO expression is classically regulated in the kidney by HIF> isoform stabilization in response to hypoxia. Given that muscle also uses HIF1> and HIF2> to adapt to hypoxia, by increasing oxidative capacity and stimulating angiogenesis, EPO may be regulated in a similar fashion as well. To test this, we exercised mice until exhaustion and measured EPO expression and HIF1> and HIF2> levels in muscle. Confirming previously observed findings, exercise training was able to increase skeletal muscle expression of EPO by 70% (P G 0.05) (Fig. 2C) . Moreover, HIF1> levels in exercised muscle were increased by 50% (P G 0.05) ( Fig. 2A) , and HIF2> levels were increased by 20% (P G 0.05) (Fig. 2B) . Both HIF> isoforms were nearly undetectable in resting muscle (see Hypoxia can induce myoblasts to stimulate erythropoiesis. Previously our group had demonstrated that long-term exercise training increased basal levels of EPO expression in skeletal muscle (3) . Moreover, we observed large increases in circulating erythrocyte progenitors after exercise. What remained unknown, however, was whether muscle itself, some other cell type within muscle, or some other tissue in general was responsible for this observation. To measure the capacity of skeletal muscle in isolation to stimulate erythropoiesis we exposed proliferating myoblasts to hypoxia and used the media from those cells to assay erythropoiesis in whole bone marrow. Ter-119 is a marker of murine hematopoietic cells in the erythroid lineage FIGURE 1-EPO expression is increased by hypoxia in myoblasts and myotubes. EPO expression in proliferating myoblasts and differentiated myotubes in response to increased temperature, mechanical stimulation, hypoxia, and decreased pH. In both proliferating myoblasts and differentiated myotubes, no stimulus other than hypoxia was able to elicit a change in EPO expression. A. In proliferating myoblasts, hypoxia increased EPO expression by 130% (P G 0.05). B. In differentiated myotubes, hypoxia increased EPO expression by 50% (P G 0.05). Data are presented as fold change from control.
(11). We observed a 32% increase (P G 0.05) in the number of Ter-119-positive cells 24 h after incubation with media conditioned by hypoxic myoblasts (Fig. 3A) . When an EPOneutralizing antibody was added to the hypoxic media, this increase was completely blocked. In a separate experiment, we observed a 67% increase (P G 0.05) in the number of Ter-119-positive cells 72 h after incubation with media conditioned by hypoxic myoblasts (Fig. 3B) 2-Effects of exercise on skeletal muscle EPO expression and HIF> levels. Effects of intense aerobic exercise on EPO expression and HIF> levels in skeletal muscle. Animals were exercised for 1 h or until exhaustion. A. HIF1> levels in the gastrocnemius were increased by 50% (P G 0.05); data are expressed as arbitrary units. B. HIF2> levels in the gastrocnemius were increased by 20% (P G 0.05); data are expressed as arbitrary units. C. EPO expression in the gastrocnemius was increased by 70% (P G 0.05); data are expressed as fold change from control.
http://www.acsm-msse.org
DISCUSSION
In this study, we have shown that both myoblasts and differentiated myotubes express the hematopoietic cytokine EPO in vitro. Of all the stimuli tested, only hypoxia was able to alter EPO expression in these cell types (Fig. 1) . Importantly, myoblasts exposed to hypoxia were able to produce EPO at physiologically meaningful levels; erythropoiesis was upregulated in bone marrow treated with media taken from hypoxic myoblasts, and this increase was ablated with the use of an EPO-neutralizing antibody (Fig. 3) . Using an exhaustive aerobic exercise protocol to promote skeletal muscle hypoxia, we were able to confirm these findings in vivo. Increased skeletal muscle HIF1> and HIF2> levels were mirrored with increased skeletal muscle EPO expression (Fig. 2) .
Very little is known about the ability of skeletal muscle to produce EPO. A handful of studies exist; however, the data are equivocal. Rundqvist et al. (23) were able to demonstrate that skeletal muscle expresses EPO and that an exercising leg can release EPO into blood. During recovery, they noted absorption of serum EPO into the exercised leg (23) . Perplexingly, they were unable to detect changes in EPO expression or protein content within muscle after exercise. Schwandt et al. (1991) performed a similar study, measuring serum EPO levels in well-trained men before, during, and after a marathon run. They were able to measure an increase in serum EPO 3 h into the run, and impressively, higher than basal levels of EPO were measured 31 h after the run (26) . Moreover, Ameln et al. (2) demonstrated increased skeletal muscle EPO expression postexercise. In a study by our group, where animals were exercised trained on a treadmill several times a week for 12 wk, we were able to measure a 93% increase in basal skeletal muscle expression of EPO (3). Strangely, in the same animals, we were also able to measure a 22% decrease in basal kidney levels of EPO.
These studies seem to suggest that exercise can increase skeletal muscle EPO expression and release of EPO into circulation. The intensity and duration of exercise also seems to have an effect, with longer training periods or more intense bouts of exercise resulting in measureable increases in EPO expression. The addition of systemic hypoxia, or hypoxemia through intense exercise, also seems to promote skeletal muscle EPO expression. Several questions, however, still remained unanswered.
The first unknown is whether myoblasts and myotubes within skeletal muscle express EPO, or if some other cell type within skeletal muscle is responsible for the observed increases in expression. In the kidney a very specialized population of fibroblasts is responsible for EPO production. These cells are found in close association with peritubular capillaries of the nephron and as a result are able to closely monitor blood oxygen levels. When levels fall, the HIF> isoforms in these cells stabilize and initiate a signaling cascade that results in increased EPO expression. Similar to the kidney, myoblasts and myotubes are found in proximity to capillaries and rely on oxygen for their ability to provide energy. HIF1> and HIF2> in these cells are also stabilized in hypoxic conditions and can help the muscle adapt to hypoxia. Here we report that both C2C12 myoblasts and myotubes are directly able to express EPO (Fig. 1) , as well as proliferating primary myoblasts.
Secondly, no attempts have been made to understand how the observed increases in skeletal muscle EPO expression are regulated. In several of the studies mentioned previously, only long-term training or very intense exercise was able to invoke increases in EPO expression. Given these discrepancies, a mechanistic approach was used to determine how exercise might increase EPO expression. To this end, we used known individual components of exercise and tested them in isolation. Performing the experiment in this fashion allowed us to maximally stress each potential pathway to elicit a result. Increased temperature, decreased pH, mechanical stretch, and hypoxia were used as each of these stimuli is associated with exercise. Although this is a crude means of mimicking exercise in vitro, we feel that these conditions cover the majority of important physiological stimuli occurring during an exercise bout.
It was observed that only hypoxia was able to increase EPO expression in both C2C12 myoblasts and myotubes, by 130% (Fig. 1A) and 50% (Fig. 1B) , respectively. Further testing revealed that hypoxia also increased EPO expression in proliferating primary myoblasts by 128%. The release of EPO from C2C12s was confirmed by an ELISA, demonstrating 36.3 T 12.1 and 39.7 T 9.5 pgImL j1 EPO in the hypoxic proliferating and differentiated conditions, respectively, with no detectable EPO in any control condition. This result was not altogether surprising, given that hypoxia serves as the classical regulator of EPO expression in the kidney. This also falls in line with the previous exercise studies mentioned. Only very intense or very long-term exercise, with or without the addition of systemic or local hypoxia, was able to increase EPO expression. In these protocols of exercise, the muscle would become hypoxic, HIF> isoforms would stabilize, and increased EPO expression would be observed.
As EPO expression is regulated in the kidney by HIF> isoforms, we wanted to design an exercise protocol capable of inducing severe oxygen depletion in an exercising muscle. A protocol of this type should be able to promote hypoxia and to allow for the stabilization of skeletal muscle HIF> isoforms. To this end, we exercised animals for 1 h or until they were unable to continue. The animals were then killed immediately. Confirming the previously mentioned finding, and the findings of some of the previous studies, intense exercise was able to increase EPO expression ( Fig. 2A) and was able to induce hypoxia severe enough to stabilize skeletal muscle HIF1> ( Fig. 2A ) and HIF2> levels (Fig. 2B) . Given that only hypoxia was able to increase EPO expression in vitro and EPO expression was associated with an increase in HIF1> and HIF2> availability in vivo, we conclude that, similar to the kidney, EPO expression in skeletal muscle is regulated in a hypoxia and HIF>-dependent manner.
Finally, whether skeletal muscle expression of EPO serves a physiologically relevant purpose has thus far remained unknown. In the case of the human studies discussed previously, or our previous work where exercise was able to increase skeletal muscle expression of EPO and increase numbers of circulating erythrocyte progenitors, any biological system responsive to exercise could have been the underlying mechanism responsible for these observations. No isolation of stimuli was possible. Although muscle expresses EPO and is responsive to exercise, nothing suggests that musclederived EPO is able to modulate erythropoiesis in any physiologically relevant manner. To answer this question, we analyzed the system independent of any other variables. C2C12 myoblasts were exposed to hypoxia, their media were collected and filtered, and that media were used to treat bone marrow isolated from healthy mice. In designing the experiment this way, the direct ability of myoblasts to stimulate erythropoiesis was tested. The result was a 32% increase in bone marrow erythropoiesis at 24 h (Fig. 3A) and a 67% increase at 72 h (Fig. 3B) , measured by Ter-119 and analyzed with flow cytometry. Supporting this result, an EPOneutralizing antibody completely ablated the observed increase at 24 h. Therefore, myoblasts exposed to hypoxia were directly able to stimulate erythropoiesis.
This result falls in line with findings from our previous study (3) . In that study, we observed a basal increase in expression of skeletal muscle EPO, a basal decrease in expression of kidney EPO, and a higher steady state level of circulating erythropoietic progenitors. If the kidney-derived EPO had solely been responsible for regulating erythropoiesis, and muscle was unable to release EPO into circulation, we previously would have observed a decrease in circulating erythropoietic progenitors. These results, along with our other work demonstrating that exercise training can increase bone marrow transplant recipient survival (6), speak to the importance of exercise on the health of the hematopoietic system and the potential clinical importance of exercise on hematopoietic health. Our current results reinforce our previous theory; exercise and skeletal muscle can act to upregulate erythropoiesis and bolster hematopoiesis.
The ability of skeletal muscle to adapt to chronic hypoxia is a well-observed phenomenon. During periods of hypoxia, muscle can upregulate angiogenic factors such as VEGF, increasing capillarization to provide more oxygenated blood to the muscle. Moreover, muscle fiber type can shift, resulting in increased glycolytic capacity and decreased need for oxygen (18) . Both these adaptations are mediated by HIF1>. That exercising muscle can also use HIF1> and HIF2> to increase expression of EPO is not surprising. This only serves as another layer of adaptation, where muscle produces additional EPO, EPO stimulates erythropoiesis, and additional oxygen can be carried to the muscle by an increased number of erythrocytes. These results demonstrate that, together with the kidney, skeletal muscle may act as an atypical regulator of erythropoiesis.
